The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer - A prospective nation-wide study in Finland

FIGO stage, residual tumor, and primary chemotherapy are significant prognostic factors for ovarian cancer. Hospital volume is associated with residual tumor. The results favor performance of ovarian cancer surgery in hospitals with higher operative volumes.